Pure Global AI
NCT06281080Not yet recruiting

First-in-Human Trial of a Novel Endoluminal Robotic System for En-Bloc Resection of Bladder Tumours

Chinese University of Hong KongClinicalTrials.govprocedure
Verified
Study focus
Disease/Condition
Bladder Cancer
Drug/Device/Intervention
En-Bloc Resection of Bladder Tumours
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
Chinese University of Hong Kong
Timeline & enrollment
Phase
N/A
Start date
Jul 01, 2024
End date
Sep 30, 2025
Enrollment
10 participants
Primary outcome

Successful en-bloc tumour resection by the robotic system

Summary

This is a prospective, single-arm study to evaluate the feasibility and safety of performing
 transurethral en-bloc resection of bladder tumours using the Zenith robotic system.

ICD-10 classifications
Malignant neoplasm of bladderMalignant neoplasm: Bladder, unspecifiedMalignant neoplasm: Dome of bladderMalignant neoplasm: Overlapping lesion of bladderMalignant neoplasm: Lateral wall of bladder
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06281080
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06281080 through Pure Global AI's free database. This phase not specified trial is sponsored by Chinese University of Hong Kong and is currently Not yet recruiting. The study focuses on Bladder Cancer. Target enrollment is 10 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.